Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...

Learn how frameworks like Solid, Svelte, and Angular are using the Signals pattern to deliver reactive state without the ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

More than 75 health systems sent a letter to federal officials calling for stronger oversight of nationwide data sharing networks, flagging issues with "bad actors" gaining access to patients' medical ...

Since 2023, multiple security investigations have highlighted a growing trend in which China-linked threat actors increasingly rely on lightweight, stealthy command-and-control (C2) tooling to manage ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

The Senate Banking Committee postponed its scheduled markup of a key crypt bill this week after Coinbase CEO Brian Armstrong pulled support for its draft text. Shares of crypto companies such as ...

The Duffer Brothers didn’t have a Hollywood free pass—just a camcorder and a mom who didn’t direct their destiny. When I picture the Duffer brothers at 8 years old, it’s not in a writer’s room in ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new ...

The Pilot competes with three-row SUVs like the Chevrolet Traverse, Ford Explorer, Hyundai Palisade, Kia Telluride, Nissan Pathfinder, Mazda CX-70, Toyota Grand Highlander and VW Atlas. The Pilot is ...